Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
AVXL
AVXL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AVXL News
Anavex Life Sciences Q1 2026 Earnings Call Insights
6d ago
seekingalpha
Anavex Life Sciences Q1 Earnings Beat Expectations
Feb 09 2026
seekingalpha
Anavex Reports Q1 Fiscal 2026 Financial Results and Pipeline Progress
Feb 09 2026
Newsfilter
Danaher Exceeds Q4 Earnings Guidance but Faces Market Skepticism
Jan 28 2026
CNBC
Anavex Joins ACCESS-AD Initiative to Accelerate Alzheimer's Disease Treatment Adoption
Jan 13 2026
Globenewswire
Anavex Life Sciences Faces Investigation Over Misleading Information, Stock Plummets 35.94%
Jan 09 2026
PRnewswire
Anavex Life Sciences Faces Securities Fraud Investigation After 36% Stock Drop
Jan 08 2026
PRnewswire
Anavex Life Sciences Faces Securities Fraud Claims as Stock Plummets 36%
Dec 30 2025
Globenewswire
Anavex Shares Plunge 35.9% Following Negative EMA Vote on Drug Application
Dec 24 2025
Globenewswire
Anavex Life Sciences Asks European Medicines Agency to Reassess Blarcamesine for Early Alzheimer's Therapy
Dec 18 2025
Yahoo Finance
Anavex Requests EMA to Reassess Its Negative Stance on Blarcamesine for Alzheimer's Treatment
Dec 18 2025
SeekingAlpha
Anavex Requests Re-examination of Blarcamesine for Alzheimer's Disease
Dec 12 2025
Globenewswire
Anavex Requests Re-examination of Blarcamesine for Alzheimer's Disease
Dec 12 2025
Newsfilter
EMA advises against approval of Anavex's blarcamesine for Alzheimer's treatment.
Dec 12 2025
SeekingAlpha
Anavex Life Sciences Faces Investigation After 35.9% Share Drop Following EMA Negative Vote
Dec 04 2025
Businesswire
Marvell Reports Impressive Q3 Earnings, Alongside American Eagle, Microchip Technology, Box, and Other Major Stocks Rising on Wednesday
Dec 03 2025
Benzinga
Show More News
